Literature DB >> 27903797

Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Hayato Murakoshi1, Madoka Koyanagi1, Takayuki Chikata1, Mohammad Arif Rahman1, Nozomi Kuse1, Keiko Sakai1, Hiroyuki Gatanaga1,2, Shinichi Oka1,2, Masafumi Takiguchi3.   

Abstract

HLA-B*52:01-C*12:02, which is the most abundant haplotype in Japan, has a protective effect on disease progression in HIV-1-infected Japanese individuals, whereas HLA-B*57 and -B*27 protective alleles are very rare in Japan. A previous study on HLA-associated polymorphisms demonstrated that the number of HLA-B*52:01-associated mutations at four Pol positions was inversely correlated with plasma viral load (pVL) in HLA-B*52:01-negative individuals, suggesting that the transmission of HIV-1 with these mutations could modulate the pVL in the population. However, it remains unknown whether these mutations were selected by HLA-B*52:01-restricted CTLs and also reduced viral fitness. In this study, we identified two HLA-B*52:01-restricted and one HLA-C*12:02-restricted novel cytotoxic T-lymphocyte (CTL) epitopes in Pol. Analysis using CTLs specific for these three epitopes demonstrated that these CTLs failed to recognize mutant epitopes or more weakly recognized cells infected with mutant viruses than wild-type virus, supporting the idea that these mutations were selected by the HLA-B*52:01- or HLA-C*12:02-restricted T cells. We further showed that these mutations reduced viral fitness, although the effect of each mutation was weak. The present study demonstrated that the accumulation of these Pol mutations selected by HLA-B*52:01- or HLA-C*12:02-restricted CTLs impaired viral replication capacity and thus reduced the pVL. The fitness cost imposed by the mutations partially accounted for the effect of the HLA-B*52:01-C*12:02 haplotype on clinical outcome, together with the effect of HLA-B*52:01-restricted CTLs on viral replication, which had been previously demonstrated. IMPORTANCE: Numerous population-based studies identified HLA-associated HIV-1 mutations to predict HIV-1 escape mutations from cytotoxic T lymphocytes (CTLs). However, the majority of these HLA-associated mutations have not been identified as CTL escape mutations. Our previous population-based study showed that five HLA-B*52:01-associated mutations at four Pol positions were inversely correlated with the plasma viral load in HLA-B*52:01-negative Japanese individuals. In the present study, we demonstrated that these mutations were indeed selected by CTLs specific for novel B*52:01- and C*12:02-restricted epitopes and that the accumulation of these mutations reduced the viral fitness in vitro This study elucidated the mechanism by which the accumulation of these CTL escape mutations contributed to the protective effect of the HLA-B*52:01-HLA-C*12:02 haplotype on disease progression in HIV-1-infected Japanese individuals.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CTL; HIV-1; escape mutation

Mesh:

Substances:

Year:  2017        PMID: 27903797      PMCID: PMC5286884          DOI: 10.1128/JVI.02082-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

2.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent.

Authors:  Takuya Naruto; Hiroyuki Gatanaga; George Nelson; Keiko Sakai; Mary Carrington; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies.

Authors:  S Karaki; A Kariyone; N Kato; K Kano; Y Iwakura; M Takiguchi
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

7.  Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.

Authors:  Melissa M Norström; Marcus Buggert; Johanna Tauriainen; Wendy Hartogensis; Mattia C Prosperi; Mark A Wallet; Frederick M Hecht; Marco Salemi; Annika C Karlsson
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

8.  Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.

Authors:  Alasdair Leslie; Philippa C Matthews; Jennifer Listgarten; Jonathan M Carlson; Carl Kadie; Thumbi Ndung'u; Christian Brander; Hoosen Coovadia; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

9.  Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.

Authors:  Zabrina L Brumme; Chun Li; Toshiyuki Miura; Jennifer Sela; Pamela C Rosato; Chanson J Brumme; Tristan J Markle; Eric Martin; Brian L Block; Alicja Trocha; Carl M Kadie; Todd M Allen; Florencia Pereyra; David Heckerman; Bruce D Walker; Mark A Brockman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

10.  Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations.

Authors:  Kuan-Hsiang Gary Huang; Dominique Goedhals; Jonathan M Carlson; Mark A Brockman; Swati Mishra; Zabrina L Brumme; Stephen Hickling; Christopher S W Tang; Toshiyuki Miura; Chris Seebregts; David Heckerman; Thumbi Ndung'u; Bruce Walker; Paul Klenerman; Dewald Steyn; Philip Goulder; Rodney Phillips; Cloete van Vuuren; John Frater
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

View more
  10 in total

1.  Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.

Authors:  Chu Wang; Donglai Liu; Tao Zuo; Bhavna Hora; Fangping Cai; Haitao Ding; John Kappes; Christina Ochsenbauer; Wei Kong; Xianghui Yu; Tanmoy Bhattacharya; Alan S Perelson; Feng Gao
Journal:  J Infect       Date:  2019-12-05       Impact factor: 6.072

2.  Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.

Authors:  Maribel Soto-Nava; Santiago Avila-Ríos; Humberto Valenzuela-Ponce; Claudia García-Morales; Jonathan M Carlson; Daniela Tapia-Trejo; Daniela Garrido-Rodriguez; Selma N Alva-Hernández; Thalía A García-Tellez; Akio Murakami-Ogasawara; Simon A Mallal; Mina John; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Gustavo Reyes-Teran
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

3.  Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.

Authors:  Chengcheng Zou; Hayato Murakoshi; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Tomáš Hanke; Masafumi Takiguchi
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

Review 4.  Interaction of the Host and Viral Genome and Their Influence on HIV Disease.

Authors:  Riley H Tough; Paul J McLaren
Journal:  Front Genet       Date:  2019-01-23       Impact factor: 4.599

5.  Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.

Authors:  Takayuki Chikata; Wayne Paes; Tomohiro Akahoshi; Thomas Partridge; Hayato Murakoshi; Hiroyuki Gatanaga; Nicola Ternette; Shinichi Oka; Persephone Borrow; Masafumi Takiguchi
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.

Authors:  Tomohiro Akahoshi; Hiroyuki Gatanaga; Nozomi Kuse; Takayuki Chikata; Madoka Koyanagi; Naoki Ishizuka; Chanson J Brumme; Hayato Murakoshi; Zabrina L Brumme; Shinichi Oka; Masafumi Takiguchi
Journal:  PLoS Pathog       Date:  2020-12-28       Impact factor: 6.823

7.  Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.

Authors:  Hung The Nguyen; Nozomi Kuse; Yu Zhang; Hayato Murakoshi; Yosuke Maeda; Yoshiko Tamura; Rie Maruyama; Giang Van Tran; Trung Vu Nguyen; Kinh Van Nguyen; Shinichi Oka; Takayuki Chikata; Masafumi Takiguchi
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

8.  Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.

Authors:  Hayato Murakoshi; Takayuki Chikata; Tomohiro Akahoshi; Chengcheng Zou; Mohamed Ali Borghan; Giang Van Tran; Trung Vu Nguyen; Kinh Van Nguyen; Nozomi Kuse; Masafumi Takiguchi
Journal:  AIDS       Date:  2021-01-01       Impact factor: 4.632

9.  Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.

Authors:  Yu Zhang; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Hayato Murakoshi; Masafumi Takiguchi
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

10.  Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.

Authors:  Nozomi Kuse; Hayato Murakoshi; Tomohiro Akahoshi; Takayuki Chikata; Katherine L James; Hiroyuki Gatanaga; Sarah L Rowland-Jones; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.